SUMO1P3: A Potential Drug Target and Biomarker (G474338)

Target Name: SUMO1P3

NCBI ID: G474338

SUMO1P3

Other Name(s): SUMO1 pseudogene 3

SUMO1P3: A Potential Drug Target and Biomarker

SUMO1P3, also known as SUMO1 pseudogene 3, is a gene that has been identified in various scientific studies as having potential drug targets and biomarkers. SUMO1P3 is a small non-coding RNA molecule that is expressed in various tissues and cells throughout the body. It is a key regulator of cell-cell adhesion and has been shown to play a role in the development and progression of various diseases, including cancer.

One of the key features of SUMO1P3 is its ability to interact with other proteins, particularly SUMO1, which is a protein that is involved in cell-cell adhesion and has been shown to play a role in various diseases, including cancer. SUMO1P3 has been shown to physically interact with SUMO1 and can bind to its active site, which suggests a potential mechanism for its regulation by SUMO1.

SUMO1P3 has also been shown to regulate the expression of other genes, including genes involved in cell adhesion, migration, and invasion. It has been shown to promote the expression of genes involved in cell-cell adhesion and to inhibit the expression of genes involved in cell migration and invasion. This suggests that SUMO1P3 may have a role in the regulation of cell behavior and has potential as a drug target or biomarker.

In addition to its potential role in cell behavior, SUMO1P3 has also been shown to play a role in the development and progression of various diseases. For example, it has been shown to be involved in the development of cancer, particularly breast cancer. It has also been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

SUMO1P3 is also a potential biomarker for various diseases, as its expression has been shown to be altered in a variety of diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. This suggests that SUMO1P3 may be a useful biomarker for these diseases and could be targeted by drugs that are designed to reduce its expression.

In conclusion, SUMO1P3 is a gene that has been identified in various scientific studies as having potential drug targets and biomarkers. Its ability to interact with other proteins and regulate the expression of other genes suggests that it may play a role in the regulation of cell behavior and has potential as a drug target or biomarker. Further research is needed to fully understand the role of SUMO1P3 in these processes and to determine its potential as a drug.

Protein Name: SUMO1 Pseudogene 3

The "SUMO1P3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SUMO1P3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets